Compound Profile

Methyl Eugenol

Phenylpropanoid found in aromatic plants that IARC classifies as probably carcinogenic to humans (Group 2A).

Last reviewed: Report a correctionProfile-wide ·C Limited

Use extra caution — IARC classifies methyleugenol as probably carcinogenic to humans (Group 2A). Details

Evidence
Limited evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Use caution
Best for
TRP Channels, Antimicrobial Membranes, COX/LOX
Next steps

Continue reading

Methyl Eugenol monograph visual
Generated profile category visual

Safety

Safety & Cautions

IARC classifies methyleugenol as probably carcinogenic to humans (Group 2A). Direct human cancer evidence is inadequate, and the classification does not provide one risk estimate for every exposure.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

Evidence Summary

Profile-wide ·C Limited

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — Neurotransmitter Signaling Modulation · Neurotransmitter Modulation · Cellular Protection

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — IARC classifies methyleugenol as probably carcinogenic to humans (Group 2A).

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Limited evidence

Methyl Eugenol has a limited evidence rating.

AdaptogenStress & MoodLongevity
Citation density
0.3
Sources
1
Effects
4
Research recency
Mixed recency
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (1)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

What the evidence actually shows

This table contains 1 structured source, including 0 human evidence sources; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

IARC Monographs Volume 134: Aspartame, Methyleugenol, and Isoeugenol

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

——————Source →

How Methyl Eugenol Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Methyl Eugenol Works

How Methyl Eugenol WorksMethyl Eugenol acts on biological target pathways via anti inflammatory, leading to trp channels.Methyl EugenolBiological TargetBiological pathwayAnti InflammatoryTrp ChannelsObservable outcomeNeurotransmitterModulation
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

No standardized dose
No standardized dose is established for this ingredient in our source data. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Neurotransmitter Signaling Modulation
  • Neurotransmitter Modulation
  • Cellular Protection
  • Oxidative Stress Modulation
  • Cytochrome P450 Enzyme Interaction
  • Inflammatory Signaling Modulation

Botanical Context

Source botanicals and comparison guides related to Methyl Eugenol.

Found in

Compare active botanicals

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

By Willie B. Randolph III

Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Suggest an ingredient, comparison, or study →

Free safety checklist

Get the Methyl Eugenol evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

← Back to compounds librarySafety checker →